Daniel Lubelski1, Joseph E Tanenbaum2,3,4, Taylor E Purvis1, Thomas T Bomberger2,3,4, Courtney Rory Goodwin1, Ilya Laufer5, Daniel M Sciubba1. 1. Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. 2. Cleveland Clinic Center for Spine Health, Cleveland Clinic, Cleveland, OH, 44195, USA. 3. Department of Neurological Surgery, Cleveland Clinic, Cleveland, OH, 44195, USA. 4. Case Western Reserve University School of Medicine, Cleveland, OH, 44106, USA. 5. Department of Neurosurgery, Memorial Sloan Kettering Hospital, New York, NY, 10022, USA.
Abstract
AIM: to identify preoperative factors associated with morbidity/mortality, hospital length of stay (LOS), 30-day readmission and operation rates following spinal stereotactic radiosurgery (SRS) for spinal tumors. METHODS: The American College of Surgeons National Quality Improvement Program was queried from 2012 to 2014 to identify patients undergoing SRS for spinal tumors. Logistic regression was performed to identify predictors. RESULTS: 2714 patients were identified; 6.8% had major morbidity or mortality, 6.9% were readmitted within 30 days and 4.3% had a subsequent operation within 30 days. Age, BMI and American Society of Anesthesiologist (ASA) class were predictive of LOS. Major morbidity was predicted by age >80, BMI >35, high ASA, pretreatment functional dependence and baseline comorbidities. Predictors of operation within 30 days included preoperative steroid use, renal failure, BMI >35 and if the treatment was nonelective. DISCUSSION: 4-7% of patients undergoing SRS for spinal tumors have morbidity following the procedure. Factors predictive of morbidity, LOS, and subsequent operation included age, BMI, baseline comorbidities and functional status. CONCLUSION: Identification of preoperative patient-specific factors that are predictive of post-treatment outcome will aid in patient selection and patient counseling leading to greater patient satisfaction and hospital efficiency.
AIM: to identify preoperative factors associated with morbidity/mortality, hospital length of stay (LOS), 30-day readmission and operation rates following spinal stereotactic radiosurgery (SRS) for spinal tumors. METHODS: The American College of Surgeons National Quality Improvement Program was queried from 2012 to 2014 to identify patients undergoing SRS for spinal tumors. Logistic regression was performed to identify predictors. RESULTS: 2714 patients were identified; 6.8% had major morbidity or mortality, 6.9% were readmitted within 30 days and 4.3% had a subsequent operation within 30 days. Age, BMI and American Society of Anesthesiologist (ASA) class were predictive of LOS. Major morbidity was predicted by age >80, BMI >35, high ASA, pretreatment functional dependence and baseline comorbidities. Predictors of operation within 30 days included preoperative steroid use, renal failure, BMI >35 and if the treatment was nonelective. DISCUSSION: 4-7% of patients undergoing SRS for spinal tumors have morbidity following the procedure. Factors predictive of morbidity, LOS, and subsequent operation included age, BMI, baseline comorbidities and functional status. CONCLUSION: Identification of preoperative patient-specific factors that are predictive of post-treatment outcome will aid in patient selection and patient counseling leading to greater patient satisfaction and hospital efficiency.
Entities:
Keywords:
30 day readmission; American College of Surgeons National Quality Improvement Program; major morbidity and mortality; predictors; spinal stereotactic radiosurgery; spinal tumors
Authors: Anne M Suskind; Louise C Walter; Chengshi Jin; John Boscardin; Saunak Sen; Matthew R Cooperberg; Emily Finlayson Journal: BJU Int Date: 2016-01-17 Impact factor: 5.588
Authors: Javier Z Guzman; James C Iatridis; Branko Skovrlj; Holt S Cutler; Andrew C Hecht; Sheeraz A Qureshi; Samuel K Cho Journal: Spine (Phila Pa 1976) Date: 2014-09-01 Impact factor: 3.468
Authors: Peter S Rose; Ilya Laufer; Patrick J Boland; Andrew Hanover; Mark H Bilsky; Josh Yamada; Eric Lis Journal: J Clin Oncol Date: 2009-09-08 Impact factor: 44.544
Authors: David J Cote; Aditya V Karhade; William T Burke; Alexandra M G Larsen; Timothy R Smith Journal: Acta Neurochir (Wien) Date: 2016-06-23 Impact factor: 2.216
Authors: Shukri F Khuri; William G Henderson; Jennifer Daley; Olga Jonasson; R Scott Jones; Darrell A Campbell; Aaron S Fink; Robert M Mentzer; Leigh Neumayer; Karl Hammermeister; Cecilia Mosca; Nancy Healey Journal: Ann Surg Date: 2008-08 Impact factor: 12.969
Authors: William A Ranson; Samuel J W White; Zoe B Cheung; Christopher Mikhail; Ivan Ye; Jun S Kim; Samuel K Cho Journal: Global Spine J Date: 2018-05-10